Inhaled Corticosteroids and Chronic Lung Disease

The jury is still out on whether inhaled corticosteroids slow the decline in lung function for patients with chronic obstructive pulmonary disease (COPD). COPD, which is characterized by limited airflow, is the fourth leading cause of death in the U.S.
canadian antibiotics

Researchers from the Medical University of South Carolina say that the tradeoff of long-term improvement might not be worth the persistent effects of the drugs, and they support inhaled cortico-steroids for symptomatic patients who have a spirometric response to them or who have frequent COPD exacerbations that require the use of oral cortico-steroids or antibiotics.